📊 Analyst Consensus & Targets
- Analyst Rating: None
- Price Target: $69.66667
- Sector: Healthcare – Biotechnology
💡 The Growth Thesis
None Consensus: Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. Analysts project a 18.5% potential upside. Currently trading at a Forward P/E of 27.070944.